All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
Erlolieva 150mg Tablet_203372 (1)
Erlolieva 150mg Tablet_203372 (2)
Erlolieva 150mg Tablet_203372 (1)
81% Off

Erlolieva 150mg Tablet

Prescription Required

Salt Composition : Erlotinib

Manufacturer : Allieva Pharma Pvt. Ltd.

Origin of Medicine : India

MRP: 9360
Price : 1800
You Save : 7560 (81%)

30 Tablet(s) In A Bottle

Pincode
Delivery By -

Introduction to Erlolieva 150mg Tablet

Erlolieva 150mg Tablet is an anticancer medicine. Cancer is an abnormal and uncontrolled multiplication of cells within the body. It is used in the treatment of patients with advanced or metastatic non-small cell lung cancer. Erlolieva 150mg Tablet is given in combination with Gemcitabine to treat pancreas cancer at the metastatic stage. Administration of this medicine may lead to kidney and liver failure. Doctors will periodically monitor kidney and liver function. Inform the physician about any history of clotting disorders or medicines taken for clotting disorders, as the Erlolieva 150mg Tablet may increase the tendency to bleed.  

Inform the physician if patients develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine. Patients are advised not to smoke while treated with this medicine, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside.


Uses of Erlolieva 150mg Tablet

  • Advanced or metastatic non-small lung cancer (NSCLC)
  • Advanced or metastatic pancreatic cancer

Therapeutic Effects of Erlolieva 150mg Tablet

Erlolieva 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.


Interaction of Erlolieva 150mg Tablet with other drugs

Inform the doctor about any medications you are taking or have taken before the treatment


More Information about Erlolieva 150mg Tablet

Keep out of sight and reach of children. Store at controlled room temperature between 15°C to 30°C. Do not freeze.


How to consume Erlolieva 150mg Tablet

Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food. Contact the doctor if any missed dose or taken more.


Safety Advices for Erlolieva 150mg Tablet

Image Not Available  

Pregnancy

  

Taking Erlolieva 150mg Tablet while pregnancy can harm the baby. Patients should not take this medicine during pregnancy unless the doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.

Image Not Available  

Breast Feeding

  

You must not take an Erlolieva 150mg Tablet if the patients are breastfeeding. Consult the doctor for risks and benefits.

Image Not Available  

Lungs

  

No Data

Image Not Available  

Liver

  

This medicine is not recommended in patients with severe liver diseases. Inform the physician if the patient has any liver disorders.

Image Not Available  

Alcohol

  

No Data

Image Not Available  

Driving

  

No Data

Side Effects of Erlolieva 150mg Tablet

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious:
 

  • Persistent or severe diarrhea
  • Pain in the eye, blurred vision
  • sudden difficulty in breathing accompanied by cough and fever
  • severe pain in your abdomen
  • liver failure
     

Common:
 

  • Rash, worsened in sun-exposed areas
  • Loss of appetite, decreased weight
  • Infection
  • Headache, changes in skin sensation
  • Depression
  • Nausea
  • Mouth irritation
  • Indigestion, stomach pain, buildup of gas
  • Hair loss, dry skin, itching
  • Tiredness, fever
  • Abnormal liver function
  • Inflammation around fingernail
  • acne, cracked skin
  • bleeding from nose, stomach, intestines
  • reduced kidney function

Word of Advice

Inform the doctor if the patient has vision problems, use of contact lenses,clotting disorders,intolerance to sugar and medication taken for cholesterol before starting this medication. This medication should not be taken along with the food and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney, liver disorders as this medication is not recommended in the patient’s with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.


FAQs

Q 1. How should I take an Erlolieva 150mg Tablet?

Always take this medicine as prescribed by the doctor.The tablet must be taken at least one hour before or two hours after taking food and it should be taken at a fixed time daily.

Q 2. Does Erlolieva 150mg Tablet cause eye dryness?

Yes, this medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use of contact lenses before taking this medication.

Q 3. Can I take an Erlolieva 150mg Tablet during pregnancy?

This medication is highly unsafe in pregnancy as it can cause harmful effects in the developing baby. Avoid making plans to have children or during pregnancy while taking this medication.


Fact Box of Erlolieva 150mg Tablet

Molecule Name: ErlotinibTherapeutic class: Anti cancer drugs
Pharmacological class: Tyrosine kinase inhibitors

Indications:

Advanced or metastatic non-small lung cancer (NSCLC)

Advanced or metastatic pancreatic cancer


References

  1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
  2. Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
  3. Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf 

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.